brent saunders vesper
Saunders was one of the most practiced M&A-oriented CEOs in pharma. Brent Saunders, CEO and co-founder of Vesper Healthcare adds, “This is a significant day for Vesper Healthcare and HydraFacial as we team up with a category-creating company in the emerging area of beauty health. Saunders was the CEO of Allergan and left the company in May 2020 when it was purchased by AbbVie. He has a twin brother Wayne and a sister Reed, and they grew up on Cedarwood Road in South Whitehall, Pennsylvania. In 2013, as CEO of Bausch + Lomb, he engineered its acquisition by Valeant Pharmaceuticals (now known as Bausch Health). The public offering netted Vesper $400 million, with investors essentially buying into Saunders' track record—along with that of co-founder, CFO and former Allergan executive Manisha Narasimhan. Saunders was the CEO of Allergan and left the company in May 2020 when it was purchased by AbbVie. In addition to this, he also worked as the chief executive officer as well as president at Forest Laboratories. Saunders was born in Arizona on February 6, 1970,[2] the son of Charles Saunders, a retired urologist, and his wife Sheila. Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are acting as the joint book-running managers for the offering. But he's repeatedly dismissed that idea. As a blank check company, which was newly incorporated this year by former Allergan CEO Brent Saunders, Miami Beach-based Vesper Healthcare states it’s “effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.” Read more. [17], https://www.bloomberg.com/profile/person/3907227, "The Botox initiation of Brent Saunders, Actavis chief executive", "Brent Saunders, Parkland grad, is the Lehigh Valley's $150 billion dealmaker", "Officer Profile | Quotes | Reuters.co.in", "Drugmaker Valeant to buy Bausch & Lomb for $8.7 billion", "Actavis Changes Name to Allergan After Deal For Botox Maker", "Forest Labs names ex-Bausch & Lomb head Saunders as CEO", "Actavis to buy Forest for $25 billion; windfall for investor Icahn", "Saunders steps aside as AbbVie closes in on Allergan merger -", "Allergan's CEO Just Pledged a 'Social Contract' With Patients on Drug Prices", "Ex-Allergan CEO Saunders pops up again in 'blank cheque' company -", "Allergan's ex-CEO Brent Saunders launching blank-check company (NYSE:ABBV)", "Saunders finds life after Allergan on board at newly IPO'ed BridgeBio", "Executive Profile* Brenton L. Saunders J.D. He was the chief compliance officer for Coventry Health Care and for Thomas Jefferson University and Health System. For more information, visit www.vesperhealth.com. Brenton L. Saunders, also known as Brent Saunders (born February 6, 1970), is the CEO of Vesper Healthcare Acquisition Corp. - Brent Saunders, former Chairman and CEO of Allergan, is co-founder, CEO, President and Chairman of Vesper Healthcare. Institutional investors including Fidelity Management & Research, Redmile Group, Principal Global Investors, Camber Capital Management and Woodline Partners have committed $350 million. He told Bloomberg and CNBC he’s not looking to compete with his alma mater—now owned by AbbVie—and that there’s “plenty of room” for Vesper to co-exist with Allergan in the markets where he plans to invest. This page shows the track record and history of SAUNDERS BRENT L insider trades in Vesper Healthcare Acquisition Corp. Unit. In a return to the beauty business, former Allergan CEO Brent Saunders sealed a $1.1 billion deal for a hot and trendy med spa facial company. FL56+FL57= infinite possibilities? He speaks on "Bloomb... PRNewsWire - 4 months ago Vesper Healthcare Acquisition Corp. Oct.05 -- Vesper Heathcare Chief Executive Officer Brent Saunders discusses the outlook for an effective Covid-19 vaccine, and his intentions for his new blank-check firm. Brent Saunders – CEO and co-founder of Vesper Healthcare and Executive Chairman of NewCo . Bill Foley’s Austerlitz I and II File for IPOs Totaling $1.5B. Subscribe to FiercePharma to get industry news and updates delivered to your inbox. Brent Saunders, CEO and co-founder of Vesper Healthcare said, “This is a significant day for Vesper Healthcare and HydraFacial as we team up with a … FL56+FL57= infinite possibilities? [3], Saunders graduated from Parkland High School in 1988. That means similar aesthetics marketing tactics and a direct sales model. Vesper Healthcare chairman Brent Saunders and Clint Carnell, CEO of Hydrafacial, join "Squawk on the Street" to discuss the deal to take Hydrafacial public via SPAC. 0. Mr. Saunders has served as President, Chief Executive Officer and Chairman of the Board of Directors of Vesper Healthcare Acquisition Corp. since July 2020. • The management will be joined by Bret Saunders and Manisha Narasimhan of Vesper in executive roles. Oct.05 -- Vesper Heathcare Chief Executive Officer Brent Saunders discusses the outlook for an effective Covid-19 vaccine, and his intentions for his new blank-check firm. All rights reserved. The purchase price consists of $975 million payable at closing and up to $75 million payable upon the completion of certain identified acquisitions by… Brenton L. Saunders, also known as Brent Saunders (born February 6, 1970), is the CEO of Vesper Healthcare Acquisition Corp. Flagship's hybrid startup takes machine learning in drug discovery to the next level — and Covid-19 offers a quick test [3] He received a BA in economics and east Asian studies from the University of Pittsburgh in 1992, an MBA from Temple University Fox School of Business and Management in 1996, and a JD from Temple University Beasley School of Law in 1996. Saunders co-founded—and recently took public—Vesper Healthcare Acquisition, which is now snapping up HydraFacial with an expected close by mid-2021. Vesper CEO Brent Saunders will become executive chairman and Vesper’s CFO, Manisha Narasimhan, will become chief strategy officer. The HydraFacial Company, an experiential beauty and health company, and Vesper Healthcare Acquisition Corp., a special purpose acquisition company are set to combine in the first half of 2021.According the transaction, HydraFacial is valued at an enterprise value of $1.1 billion. Deals. 3 Speen Street, Suite 300, Framingham, MA 01701. Brent Saunders is known as the Chief Executive Officer at Vesper Healthcare Acquisition Corp. Brent previously worked as the CEO at the pharmaceutical company named Allergan. HydraFacial and Vesper Healthcare will combine, after which HydraFacial will become a public company. He joined Schering-Plough from PricewaterhouseCoopers, where he led its compliance business advisory services group. Brent Saunders, CEO and co-founder of Vesper Healthcare said, “This is a significant day for Vesper Healthcare and HydraFacial as we team up with a category-creating company in the emerging area of beauty health. RELATED: AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go. VESPER HEALTHCARE – HYDRAFACIAL SPECIAL SITUATIONS REPORT Email info@spacalpha.com Report date December 20, 2020 ... VSPR is a SPAC founded by Brent Saunders who will continue as the Executive Chairman of the combined entity. He is on the board of the Overlook Hospital Foundation. Flagship's hybrid startup takes machine learning in drug discovery to the next level — and Covid-19 offers a quick test Then, he stepped up to CEO at Forest Laboratories and quickly struck a 2014 merger deal with Actavis—and a year later, in that company's CEO seat, he led Actavis' merger with Allergan. It’s tempting to think Saunders may be looking to take on his former company Allergan, which is best known for its Botox injection, but boasts other aesthetics treatments as well. Total. Developers’ Missteps Stifle Autologous Product Development Over the past several years, considerable clinical research in regenerative medicine — such as autologous cell-based treatments, biologics and tissue engineering — has translated to the aesthetic space. Share 0. HydraFacial and Vesper Healthcare announced a definitive merger agreement at an enterprise value of $1.1 billion. 708.2k Followers, 1,586 Following, 224 Posts - See Instagram photos and videos from Brent Saunders (@brentlsaunders) Brent Saunders has found a buyer for his SPAC — and the end result is a deal worth over a billion dollars. Goldman Sachs and JPMorgan are underwriting. He was previously CEO of the pharmaceutical company Allergan,[1] the CEO and president of Forest Laboratories, and the CEO of Bausch + Lomb Incorporated. Announces Closing and Full Exercise of Underwriters' Over-Allotment Option Brent Saunders, CEO and co-founder of Vesper Healthcare adds, “This is a significant day for Vesper Healthcare and HydraFacial as we team up with a category-creating company in the emerging area of beauty health. His father is chair of the board of trustees of St. Luke's University Health Network. Hosting today’s call from Vesper Healthcare is Brent Saunders, CEO and co-Founder, and from HydraFacial, Clint Carnell, Chief Executive Officer, and Liyuan Woo, Chief Financial Officer. PRNewsWire - 2 months ago. [11] He created the "Allergan Social Contract with Patients", with the stated aim of prohibiting price gouging and offering better patient access to Allergan medicines. Vesper Healthcare CEO Brent Saunders and Clint Carnell, CEO of The HydraFacial Co., discuss the details of the merger on CNBC. The transaction has a pro forma enterprise value of $1.1 billion, the companies said. Saunders has experience in the industry, having worked with brands such as Botox Cosmetic, Dr. Scholl’s and Coppertone. [8][9][10] He was chairman, president and CEO of Allergan Plc until May 2020. Brent Saunders has found a buyer for his SPAC — and the end result is a deal worth over a billion dollars. First, but definitely not last. Vesper will pay $975 million at closing and up to $75 million in milestones pegged to future acquisitions. Vesper Healthcare Acquisition has filed to raise $400M in an IPO, with listing on the Nasdaq under the symbol "VSRU." Vesper’s CEO is Brent Saunders. Enclose phrases in quotes. Back to beauty: Former Allergan chief Saunders scoops up aesthetics company in $1.1B deal, Saunders finds life after Allergan on board at newly IPO'ed BridgeBio, AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go. Oct.05 -- Vesper Heathcare Chief Executive Officer Brent Saunders discusses the outlook for an effective Covid-19 vaccine, and his intentions for his new blank-check firm. Vesper Healthcare Acquisition Corp. I will now turn the call over to Brent Saunders. Product Overview: • The Company provides a highly effective, non-invasive skin treatment which covers both beauty and health aspects of the skin. In 2009, he was part of the executive management team at Schering-Plough when it merged with Merck. Vesper Healthcare is led by Chief Executive Officer, Brent Saunders. Reproduction in whole or part is prohibited. [5], Saunders was a partner and head of the compliance business advisory group at PricewaterhouseCoopers LLP from 2000 to 2003. Vesper was co-founded by Brent Saunders, former CEO of Allergan, Forest Laboratories, and Bausch + Lomb. For more information, visit www.vesperhealth.com. HydraFacial and Vesper Healthcare Acquisition today announced that they have entered into a definitive merger agreement. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
4 Types Of Assertion And Examples, How To Use Foreo Ufo 2, Ck2 Start Date Mod, Demon's Souls Pure Black World Tendency, Leanfire Stories Reddit, Crescent Fish Tape, Brick Red Pearl Metallic, Pat Buchanan Nixon, Jelly Sweets Bulk, Den Hot Dogs Reviews,